How localized is pathologically localized prostate cancer? The use of secondary circulating prostate cells as a marker of minimal residual disease and their association with patient outcome
Nigel P. Murray, Socrates Aedo, Cynthia Fuentealba, Eduardo Reyes, Omar Jacob
(Urol Res Pract 2017; 43: 456-461) DOI: 10.5152/tud.2017.60251